Showing results (201-210 of 264) with videos related to

Sort By:
Pageof 27
Annals of Hematology|January 13, 2016
Prognostic factors for re-mobilization using plerixafor and granulocyte colony-stimulating factor (G-CSF) in patients with malignant lymphoma or multiple myeloma previously failing mobilization with G-CSF with or without chemotherapy: the Korean multicenter retrospective studyJin Seok Kim, Dok Hyun Yoon, Seonyang Park, et al.
Current Problems in Cancer|August 29, 2021
Multicenter, phase II study of response-adapted lenalidomide-based therapy for transplant-ineligible patients with newly diagnosed multiple myeloma without high-risk featuresKwai Han Yoo, Dok Hyun Yoon, Hye Jin Kang, et al.
Annals of Hematology|May 12, 2023
RE-MIND2: comparative effectiveness of tafasitamab plus lenalidomide versus polatuzumab vedotin/bendamustine/rituximab (pola-BR), CAR-T therapies, and lenalidomide/rituximab (R2) based on real-world data in patients with relapsed/refractory diffuse large B-cell lymphomaGrzegorz S Nowakowski, Dok Hyun Yoon, Patrizia Mondello, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|June 2, 2020
Treatment with intravenous busulfan, melphalan, and etoposide followed by autologous stem cell transplantation in patients with non-Hodgkin's lymphoma: a multicenter study from the consortium for improving survival of lymphomaKyoung Ha Kim, Won Seog Kim, Seok Jin Kim, et al.
Blood|June 26, 2020
Prediction and prevention of central nervous system relapse in patients with extranodal natural killer/T-cell lymphomaHyera Kim, Hyehyun Jeong, Motoko Yamaguchi, et al.
Anticancer Research|March 14, 2013
Can concurrent chemoradiotherapy replace surgery and postoperative radiation for locally advanced stage III/IV tonsillar squamous cell carcinoma?Geumju Park, Sang-Wook Lee, Sang Yoon Kim, et al.
BMC Cancer|November 12, 2019
Ruxolitinib shows activity against Hodgkin lymphoma but not primary mediastinal large B-cell lymphomaSeok Jin Kim, Dok Hyun Yoon, Hye Jin Kang, et al.
Scientific Reports|July 2, 2020
Quantitative analysis of tumor-specific BCL2 expression in DLBCL: refinement of prognostic relevance of BCL2Jin Roh, Hyungwoo Cho, Dok Hyun Yoon, et al.
Oncotarget|August 20, 2016
Phase II trial of concurrent chemoradiotherapy with L-asparaginase and MIDLE chemotherapy for newly diagnosed stage I/II extranodal NK/T-cell lymphoma, nasal type (CISL-1008)Dok Hyun Yoon, Seok Jin Kim, Seong Hyun Jeong, et al.
European Journal of Cancer (Oxford, England : 1990)|July 10, 2012
Bortezomib in combination with CHOP as first-line treatment for patients with stage III/IV peripheral T-cell lymphomas: a multicentre, single-arm, phase 2 trialSeok Jin Kim, Dok Hyun Yoon, Hye Jin Kang, et al.
Pageof 27